Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

NPD8733

Copy Product Info
🥰Excellent
Catalog No. T9008Cas No. 696655-62-6

NPD8733 is an inhibitor of cancer cell-enhanced fibroblast migration, specifically binding to valosin-containing protein (VCP)/p97.

NPD8733

NPD8733

Copy Product Info
🥰Excellent
Purity: 98.48%
Catalog No. T9008Cas No. 696655-62-6
NPD8733 is an inhibitor of cancer cell-enhanced fibroblast migration, specifically binding to valosin-containing protein (VCP)/p97.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$30In StockIn Stock
5 mg$47In StockIn Stock
10 mg$76In StockIn Stock
25 mg$155In StockIn Stock
50 mg$251In StockIn Stock
100 mg$407In StockIn Stock
1 mL x 10 mM (in DMSO)$54In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.48%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

NPD8733 AI Summary
NPD8733 exhibits diverse bioactivities targeting multiple biological pathways and mechanisms. It shows inhibitory potency against Influenza NS1 Protein Function at 12589.3 nM, and against ELG1-dependent DNA repair in HEK293T cells with a potency of 103.2 nM. The compound impacts delayed death in the malarial parasite plastid, with potencies of 11689.1 nM over 96 hours and 2616.9 nM over 48 hours. It also inhibits interactions of HP1-beta Chromodomain with Methylated Histone Tails at 14125.4 nM. Additionally, it inhibits human tyrosyl-DNA phosphodiesterase 1 (TDP1) with potencies of 20596.2 nM in the absence of CPT and 6513.1 nM in its presence. The compound has shown inhibitory activity against AMA1-RON for developing antimalarial drugs with a potency of 7943.3 nM. However, it has relatively low inhibitory activity against GST-fused VCP, with an IC50 greater than 100,000.0 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
NPD8733 is an inhibitor of cancer cell-enhanced fibroblast migration, specifically binding to valosin-containing protein (VCP)/p97.
Chemical Properties
Molecular Weight309.32
FormulaC18H15NO4
Cas No.696655-62-6
SmilesCOc1ccc(cc1)C(=O)c1oc2ccccc2c1NC(C)=O
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 11 mg/mL (35.56 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.2329 mL16.1645 mL32.3290 mL161.6449 mL
5 mM0.6466 mL3.2329 mL6.4658 mL32.3290 mL
10 mM0.3233 mL1.6164 mL3.2329 mL16.1645 mL
20 mM0.1616 mL0.8082 mL1.6164 mL8.0822 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy NPD8733 | purchase NPD8733 | NPD8733 cost | order NPD8733 | NPD8733 chemical structure | NPD8733 formula | NPD8733 molecular weight